• About
  • Advertise
  • Privacy & Policy
  • Contact
HK Businesswire
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

    Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

    JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

    JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

    AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

    AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

    ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

    ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

    TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide

    TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide

    Global Times: Xi’s vision of a people-centered city guides China’s urban development

    Global Times: Xi’s vision of a people-centered city guides China’s urban development

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Medisafe Scandal Deepens as HK Institutions Deny Outsourcing, Despite Contradictory Interview, Vendor Evidence and Whistleblower Claims

    Geneva Invention Awards Respond to Medisafe Scandal: ‘We Will Engage Our Own Panel to Determine Any Action’

    Deloitte: Over 40% of Family Offices Prioritise Tech Amid Digital Transformation

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    Hong Kong Student Criticised for Using Outsourced AI Project to Win STEM Awards

    Xiaomi SU7 Ultra Becomes Fastest Mass-Produced EV on Nürburgring Nordschleife

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

    Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

    JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

    JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

    AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

    AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

    ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

    ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

    TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide

    TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide

    Global Times: Xi’s vision of a people-centered city guides China’s urban development

    Global Times: Xi’s vision of a people-centered city guides China’s urban development

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Medisafe Scandal Deepens as HK Institutions Deny Outsourcing, Despite Contradictory Interview, Vendor Evidence and Whistleblower Claims

    Geneva Invention Awards Respond to Medisafe Scandal: ‘We Will Engage Our Own Panel to Determine Any Action’

    Deloitte: Over 40% of Family Offices Prioritise Tech Amid Digital Transformation

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    Hong Kong Student Criticised for Using Outsourced AI Project to Win STEM Awards

    Xiaomi SU7 Ultra Becomes Fastest Mass-Produced EV on Nürburgring Nordschleife

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
HK Businesswire
No Result
View All Result
Home News PR Newswire

LONGi maintains AAA ranking in Q1 2025 PV ModuleTech Bankability Ratings

PR Newswire by PR Newswire
17 April 2025
in PR Newswire
0
LONGi maintains AAA ranking in Q1 2025 PV ModuleTech Bankability Ratings
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

XI’AN, China, April 17, 2025 /PRNewswire/ — LONGi has announced the retention of its AAA rating in PV-Tech’s Q1 2025 PV ModuleTech bankability ratings, marking the company’s 21st consecutive quarter at this top tier and underscoring its long-term commitment to quality, innovation, financial stability and leadership in the photovoltaic industry.

LONGi maintains AAA ranking
LONGi maintains AAA ranking

The PV ModuleTech bankability ratings are derived from a thorough evaluation process that examines manufacturers across several critical dimensions, including value chain strength, production capacity, global shipment profiles, capital expenditure (capex), R&D investment and cash-flow management. LONGi’s consistent AAA status reflects not only its robust operational metrics but also its dedication to advancing solar technology.

Relying on its profound technology accumulation and advanced intelligent manufacturing advantages, LONGi has made continuous breakthroughs in HPBC technology and forward-looking R&D, and its products for utility and distributed scenarios have been implemented successively.

Since the launch of the new-generation BC products based on HPBC 2.0 in May 2024, LONGi has been winning large orders globally.

At the beginning of April, LONGi signed a 226MW Hi-MO 9 module supply agreement in Greece, which marks the largest BC utility project in Europe.

At the end of March, LONGi signed a Hi-MO X10 module supply framework agreement with a total capacity of 555MW with multiple EPC companies at the South Africa International Photovoltaic and Energy Storage Exhibition. The high-power generation per unit area and anti-shading features of the products have been highly recognized by African customers.

By the end of the first quarter of 2025, the global shipments of BC modules had exceeded 30GW, and the scale of reserved orders had exceeded 40GW.

With technological innovation as its mission, LONGi has been constantly improving the R&D of conversion efficiency in the crystalline silicon and crystalline silicon-perovskite tandem tracks. Up to now, it still holds the world records in these two major tracks.

On April 11th, LONGi announced at its Wuhu base in Anhui Province, China: Through the authoritative certification of the Institute for Solar Energy Research Hamelin (ISFH) in Germany, the photoelectric conversion efficiency of its independently developed Hybrid Interdigitated-Back-Contact (HIBC) crystalline silicon solar cell has reached 27.81%, pushing the exploration of the limits of monocrystalline silicon photovoltaic cells to a new height.

At the same time, LONGi independently developed a two-terminal crystalline silicon-perovskite tandem solar cell that has achieved a conversion efficiency of 34.85%, certified by the U.S. National Renewable Energy Laboratory (NREL), once again breaking the world record for crystalline silicon-perovskite tandem cell efficiency.

The 21 consecutive AAA ratings are not only a strong testament to LONGi’s reliability but also a footnote to LONGi’s consistent commitment to product quality, stable operation, and long-termism. In the future, LONGi will continue to enhance its technological strength and risk-resistance capabilities, and work hand in hand with global partners to create a better future.

Tags: prnewswire
PR Newswire

PR Newswire

PR Newswire is the industry’s leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

Read More

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

16 July 2025
JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

16 July 2025
  • Trending
  • Comments
  • Latest
CreateAI Advances Generative AI Technology with Two Papers Accepted at Prestigious ICCV 2025

CreateAI Advances Generative AI Technology with Two Papers Accepted at Prestigious ICCV 2025

2 July 2025
Taylor’s University Continues Strong Global Performance in QS World University Rankings 2026

Taylor’s University Continues Strong Global Performance in QS World University Rankings 2026

23 June 2025

PwC: Hong Kong Set to Reclaim Global IPO Crown in 2025 as Fundraising Surges

3 July 2025
FORTUNE UNVEILS 2025 SOUTHEAST ASIA 500

FORTUNE UNVEILS 2025 SOUTHEAST ASIA 500

17 June 2025
Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

16 July 2025
JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

16 July 2025
AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

16 July 2025
ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

16 July 2025

Recent News

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

16 July 2025
JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

16 July 2025
AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

16 July 2025
ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

16 July 2025
HK Businesswire

Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.

📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com

Follow Us

  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 by HKBusinesswire.com

No Result
View All Result

© 2025 by HKBusinesswire.com